Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
EC Approves Astellas' XOSPATA(TM) for Patients with Relapsed or Refractory Acute Myeloid Leukemia with Mutations Detected using Invivoscribe's LeukoStrat(R) CDx FLT3 Mutation Assay 2019-10-30 18:00
CEM Corporation acquires key assets of Intavis Bioanalytical Instruments 2019-10-29 20:30
Werum IT Solutions honored with Frost & Sullivan Customer Value Leadership Award 2019-10-28 22:00
EW Nutrition Opens New Production Plant in China 2019-10-28 19:08
Kazia Raises A$4.0 Million to Progress R&D Programs 2019-10-28 10:16
HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH) 2019-10-28 08:38
WuXi STA's Jinshan Facility Passes EMA Inspection 2019-10-28 08:00
Chugai Renews License to EpiVax's ISPRI In Silico Toolkit for Immunogenicity Assessment 2019-10-23 04:10
TissueCypher® Further Validated to Accurately Risk Stratify Barrett's Esophagus Patients With Non-Dysplastic or Low-Grade Dysplasia Diagnoses: Findings Shared at Two Major GI Conferences 2019-10-23 01:59
Innovent Biologics Announces Positive Updated Result from the Incyte-sponsored Phase II Trial of Pemigatinib in Patients with Previously Treated, Advanced Cholangiocarcinoma 2019-10-21 08:00
GELITA & Geltor Sign Letter of Intent to Commercialize First Animal-Free Biodesigned Collagen for Dietary Supplements, a Market with Huge Growth Potential 2019-10-17 18:32
MetGen Earns Acclaim from Frost & Sullivan for its Unique, Customized Enzyme Technologies, METNIN™ and ENZINE® 2019-10-17 15:00
Curiox Biosystems Achieves Commercialisation and Fund Raising Success in North Asia with the Support of Cornerstone Investor, ZIG Ventures 2019-10-16 07:00
Celemics Expedites Target Enrichment NGS Data Insights by Partnering With BlueBee on a Global Genomics Data Solution 2019-10-15 19:00
CTFH and Insilico Medicine Enter Al Drug Discovery Collaboration Focused On Accelerating First-in-Class Therapeutics, Worth Up to $200 million 2019-10-09 20:58
Datar Cancer Genetics Announces Positive Results With 42.9% Objective Response Rate, and 90.5% Disease Control Rate in Heavily Pre-treated Patients With Ultra-personalised Pan-cancer Treatment Protocol in the RESILIENT Trial 2019-10-09 17:56
Ascletis Appoints Former Novartis Global Head Dr. Handan He as Chief Scientific Officer 2019-10-08 08:00
Cross-industrial technologies make a splash in Asia Agri-Tech Expo in Taipei 2019-10-05 10:06
AGC Biologics Appoints New Site Head/General Manager of Copenhagen, Denmark Operations 2019-10-01 07:00
Interleukin 11 Identified as New Therapeutic Target for Idiopathic Pulmonary Fibrosis 2019-09-30 15:00
1 177 178 179 180 181 229